1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. JOHNSON & JOHNSON
Johnson & Johnson
XNYS: JNJ

Johnson & Johnson Live Stock Price Today, Share Analysis and Chart

Mid-range Performer
about

Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After...

Read More
239.07 -1.03 (-0.43%)
63.61% Gain from 52W Low
624.8K
XNYS Volume

XNYS 15 Apr, 2026 9:58 AM (EDT)

Watchlist

Portfolio

Alert
Estimates Beat
J&J's Q1 revenue beats Forecaster estimates by 2%, led by higher sales of cancer & psoriasis drugs See details
Durability score
Medium Financial Strength
38.9 / 100
Valuation Score
Mid Valuation
42.2 / 100
Momentum Score
Technically Neutral
56.8 / 100
Mid-range Performer These stocks have average quality, financial and technical momentum, indicating a mid range performer View Similar Embed DVM
Analyst Price Target
242
1Yr Price target upside is 1%
24 analysts

14

S

4

W

5

O

0

T

SWOT Analysis

Johnson & Johnson Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..